Advertisement

Reactions Weekly

, Volume 1738, Issue 1, pp 155–155 | Cite as

Ipilimumab/nivolumab/pembrolizumab

Progressive transverse myelitis: case report
Case report
  • 24 Downloads

Reference

  1. Chang VA, et al. Infliximab for treatment-refractory transverse myelitis following immune therapy and radiation. Journal for ImmunoTherapy of Cancer 6: 153, No. 1, 22 Dec 2018. Available from: URL: http://doi.org/10.1186/s40425-018-0471-2 - USA

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations